International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14550628
Original Research Article
Diagnosis of Acute Ischemic Stroke by CT scan and Diffusion Weighted MRI
Published
Dec. 24, 2024
Abstract

Background: Acute ischemic stroke is the leading cause of death and disability. An accurate and practical understanding of imaging modalities is essential for the management of the acute stroke patients. Due to its widespread availability and speed, unenhanced Computed Tomography (CT) scan remains the initial study of choice for evaluating an acute stroke patients and Diffusion Weighted Magnetic Resonance Imaging (DWMRI) can detect abnormalities due to ischemia within 3 to 30 minutes of onset, when conventional MRI and CT images would still appear normal.Objective: To compare the diagnostic role of CT scan and DWMRI in acute ischemic stroke and establish the agreement between them.Methods: This cross-sectional study was performed on 110 patients from the Department of Radiology and Imaging, BSM Medical University Hospital, Dhaka, Bangladesh from July 2023 to August 2024. Patients were immediately transferred to the Department of Radiology and Imaging where they underwent comprehensive CT scans. Suspicion of acute ischemic stroke was present.Results: Total 110 patients were enrolled in this study. Almost one third (32.7%) patients belonged to age ≥70 years. The mean age was 61.11±12.49 years with range from 32 to 90 years. Almost two third patients were male (60%) followed by (40%) female. More than (38.2%) patients were retired from job, followed by house wife (34.5%). It was observed that 20 (20%) patients experienced headache, (32.7%) vertigo, (49.1%) vomiting, (70.9%) hemiparesis/hemiplegia, Majority (81.8%) had speech disturbance. The location of infarct showed that (23.6%) patients were in M1 segment (anterior circulation ASPECTS) followed by 52 (47.3%) in lentiform nucleus and 52 (47.3%) in internal capsule. Mass Effect were observed in both CT and DWMRI in 14 (12.7%) cases. More than (76.4%) patients showed parenchymal hypoattenuation (CT) and diffusion restriction (MRI) [CT, 76.4% and DWMRI, 78.2%]. Regarding ADC value, it was observed that majority (74.5%) patients were below 0.6X10-3 mm2/s. The agreement analysis of the two modalities (parenchymal hypoattenuation (CT) with diffusion restriction (MRI)) was found showing a Kappa value of 0.858 and p value <0.01. Conclusion: DWI-MRI is a better imaging method in detecting early ischemic lesions in acute ischemic stroke patients.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
583 Views
36 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved